Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-L1 Expression Status Predicting Survival in Pulmonary Pleomorphic Carcinoma.
Hisakane K, Seike M, Sugano T, Matsuda K, Kunugi S, Nakamichi S, Matsumoto M, Miyanaga A, Noro R, Minegishi Y, Kubota K, Gemma A. Hisakane K, et al. Among authors: sugano t. Anticancer Res. 2021 May;41(5):2501-2509. doi: 10.21873/anticanres.15028. Anticancer Res. 2021. PMID: 33952478
MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation.
Noro R, Seike M, Zou F, Soeno C, Matsuda K, Sugano T, Nishijima N, Matsumoto M, Kitamura K, Kosaihira S, Minegishi Y, Yoshimura A, Kubota K, Gemma A. Noro R, et al. Among authors: sugano t. BMC Cancer. 2015 Feb 6;15:31. doi: 10.1186/s12885-015-1019-1. BMC Cancer. 2015. PMID: 25886066 Free PMC article.
Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression.
Tozuka T, Seike M, Minegishi Y, Kitagawa S, Kato T, Takano N, Hisakane K, Takahashi S, Kobayashi K, Kashiwada T, Sugano T, Takeuchi S, Kunugi S, Noro R, Saito Y, Kubota K, Gemma A. Tozuka T, et al. Among authors: sugano t. Onco Targets Ther. 2018 Sep 7;11:5601-5605. doi: 10.2147/OTT.S168598. eCollection 2018. Onco Targets Ther. 2018. PMID: 30237726 Free PMC article.
Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis.
Tozuka T, Sugano T, Noro R, Takano N, Hisakane K, Takahashi S, Tanaka T, Kashiwada T, Takeuchi S, Kunugi S, Minegishi Y, Saito Y, Kubota K, Seike M, Gemma A. Tozuka T, et al. Among authors: sugano t. Oxf Med Case Reports. 2018 Oct 22;2018(11):omy094. doi: 10.1093/omcr/omy094. eCollection 2018 Nov. Oxf Med Case Reports. 2018. PMID: 30364514 Free PMC article.
399 results